[Use of urokinase during surgery: a new approach to the treatment of vascular obliterative disease (author's transl)].
Thrombolysis occurred in five out of eleven patients treated with intra-arterial urokinase for recent raterial obliteration. These positive results were accompanied by perfect tolerance and absence of systemic fibrinolysis. In some cases, therefore, surgical revascularization can be associated with fibrinolytic treatment.
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000601:surgery; D010450:Endopeptidases / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage* / Q000627:therapeutic use
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Chirurgie-urokinase. Un nouvel abord de la pathologie vasculaire.